As of Mar 30
| +4.14 / +7.92%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 50.00, with a high estimate of 59.00 and a low estimate of 40.00. The median estimate represents a -11.35% decrease from the last price of 56.40.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.